• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).慢性肾脏病患者的冠状动脉钙化风险因素(来自慢性肾功能不全队列研究)。
Am J Cardiol. 2012 Dec 15;110(12):1735-41. doi: 10.1016/j.amjcard.2012.07.044. Epub 2012 Sep 14.
2
Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study.慢性肾脏病患者冠状动脉钙化进展的危险因素:CRIC 研究。
Atherosclerosis. 2018 Apr;271:53-60. doi: 10.1016/j.atherosclerosis.2018.02.009. Epub 2018 Feb 10.
3
Relation of a coronary artery calcium score higher than 400 to coronary stenoses detected using multidetector computed tomography and to traditional cardiovascular risk factors.冠状动脉钙化评分高于400与使用多排计算机断层扫描检测到的冠状动脉狭窄及传统心血管危险因素的关系。
Am J Cardiol. 2008 May 15;101(10):1444-7. doi: 10.1016/j.amjcard.2008.01.022. Epub 2008 Mar 17.
4
Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study.基于血清胱抑素 C 估算的肾功能和肾功能正常的中青年人群中随后发生冠状动脉钙的风险:来自 CARDIA 研究的结果。
Am J Epidemiol. 2013 Aug 1;178(3):410-7. doi: 10.1093/aje/kws581. Epub 2013 Jun 27.
5
Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study).肾功能指标以及冠状动脉和腹主动脉钙化情况(来自弗雷明汉后代研究)。
Am J Cardiol. 2008 Aug 15;102(4):440-3. doi: 10.1016/j.amjcard.2008.04.007. Epub 2008 May 22.
6
Associations between calcium-phosphate metabolism and coronary artery calcification; a cross sectional study of a middle-aged general population.钙磷代谢与冠状动脉钙化之间的关联;一项中年普通人群的横断面研究。
Atherosclerosis. 2016 Aug;251:101-108. doi: 10.1016/j.atherosclerosis.2016.06.001. Epub 2016 Jun 2.
7
Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.CRIC(慢性肾脏病队列研究)研究中估算肾小球滤过率与冠状动脉钙化的关系。
Am J Kidney Dis. 2011 Oct;58(4):519-26. doi: 10.1053/j.ajkd.2011.04.024. Epub 2011 Jul 23.
8
Eligibility of individuals with subclinical coronary artery calcium and intermediate coronary heart disease risk for reclassification (from the Framingham Heart Study).亚临床冠状动脉钙化和中度冠心病风险个体重新分类的资格(来自弗雷明汉心脏研究)
Am J Cardiol. 2009 Jun 15;103(12):1710-5. doi: 10.1016/j.amjcard.2009.02.020. Epub 2009 May 3.
9
Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients.胰岛素抵抗与 3-5 期慢性肾脏病患者的成纤维细胞生长因子 23 相关。
J Diabetes Complications. 2014 Jan-Feb;28(1):61-5. doi: 10.1016/j.jdiacomp.2013.09.004. Epub 2013 Oct 11.
10
Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers.比较冠状动脉钙和胸主动脉钙在低剂量非门控计算机断层扫描在高危重度吸烟人群中的全因死亡率和心血管事件的预测价值。
Atherosclerosis. 2010 Apr;209(2):455-62. doi: 10.1016/j.atherosclerosis.2009.09.031. Epub 2009 Sep 26.

引用本文的文献

1
Correlation of Vascular Calcification With Frailty and Quality of Life in Chronic Kidney Disease Stage 4 and 5 Non-dialysis Patients.慢性肾脏病4期和5期非透析患者血管钙化与衰弱及生活质量的相关性
Cureus. 2025 Feb 24;17(2):e79549. doi: 10.7759/cureus.79549. eCollection 2025 Feb.
2
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.慢性肾脏病患者冠状动脉钙化进展与临床事件风险:慢性肾功能不全队列研究
Am J Kidney Dis. 2025 Jan;85(1):67-77.e1. doi: 10.1053/j.ajkd.2024.06.018. Epub 2024 Aug 16.
3
Association between IL-2 Receptor and Severe Coronary Artery Calcification in Patients with Coronary Artery Disease.冠心病患者白细胞介素-2受体与严重冠状动脉钙化之间的关联
Rev Cardiovasc Med. 2024 May 23;25(5):186. doi: 10.31083/j.rcm2505186. eCollection 2024 May.
4
Association between the homeostasis model assessment of insulin resistance and coronary artery calcification: a meta-analysis of observational studies.胰岛素抵抗的稳态模型评估与冠状动脉钙化的关系:观察性研究的荟萃分析。
Front Endocrinol (Lausanne). 2023 Nov 27;14:1271857. doi: 10.3389/fendo.2023.1271857. eCollection 2023.
5
Envelope method with ignorable missing data.带有可忽略缺失数据的包络法。
Electron J Stat. 2021;15(2):4420-4461. doi: 10.1214/21-ejs1881. Epub 2021 Sep 14.
6
Ankle-Brachial Index Predicts Long-Term Renal Outcomes in Acute Stroke Patients.踝臂指数可预测急性卒中患者的长期肾脏预后。
Healthcare (Basel). 2022 May 13;10(5):913. doi: 10.3390/healthcare10050913.
7
Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review.慢性肾脏病相关血管钙化风险及潜在风险介导因素的性别差异:一项范围综述
Healthcare (Basel). 2021 Aug 1;9(8):979. doi: 10.3390/healthcare9080979.
8
Role of Uremic Toxins in Early Vascular Ageing and Calcification.尿毒症毒素在早期血管老化和钙化中的作用。
Toxins (Basel). 2021 Jan 3;13(1):26. doi: 10.3390/toxins13010026.
9
Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease.胰岛素抵抗与肾脏病患者的亚临床血管损伤有关。
Curr Cardiol Rev. 2021;17(5):e160721189014. doi: 10.2174/1573403X16999201210200012.
10
Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.尿毒症毒素与血管钙化——只见树木,不见森林。
Toxins (Basel). 2020 Sep 29;12(10):624. doi: 10.3390/toxins12100624.

本文引用的文献

1
Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.CRIC(慢性肾脏病队列研究)研究中估算肾小球滤过率与冠状动脉钙化的关系。
Am J Kidney Dis. 2011 Oct;58(4):519-26. doi: 10.1053/j.ajkd.2011.04.024. Epub 2011 Jul 23.
2
Statistical modeling of Agatston score in multi-ethnic study of atherosclerosis (MESA).动脉粥样硬化多民族研究(MESA)中 Agatston 评分的统计建模。
PLoS One. 2010 Aug 9;5(8):e12036. doi: 10.1371/journal.pone.0012036.
3
Vascular calcification in chronic kidney disease.慢性肾脏病中的血管钙化。
Clin Sci (Lond). 2010 Apr 28;119(3):111-21. doi: 10.1042/CS20090631.
4
Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis.炎症标志物与冠状动脉钙化的相关性:来自动脉粥样硬化多民族研究的结果。
Atherosclerosis. 2010 Mar;209(1):226-9. doi: 10.1016/j.atherosclerosis.2009.08.037. Epub 2009 Aug 28.
5
Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.慢性肾脏病患者冠状动脉钙化的发生率及进展:动脉粥样硬化多民族研究
Kidney Int. 2009 Nov;76(9):991-8. doi: 10.1038/ki.2009.298. Epub 2009 Aug 19.
6
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.慢性肾功能不全队列(CRIC)研究:基线特征及其与肾功能的关联
Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11. doi: 10.2215/CJN.00070109. Epub 2009 Jun 18.
7
Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis.血管钙化作为心血管风险增加的标志物:一项荟萃分析。
Vasc Health Risk Manag. 2009;5(1):185-97. doi: 10.2147/vhrm.s4822. Epub 2009 Apr 8.
8
Association of serum phosphate with vascular and valvular calcification in moderate CKD.中度慢性肾脏病患者血清磷酸盐与血管及瓣膜钙化的关联
J Am Soc Nephrol. 2009 Feb;20(2):381-7. doi: 10.1681/ASN.2008040349. Epub 2008 Dec 10.
9
Adipokines, insulin resistance, and coronary artery calcification.脂肪因子、胰岛素抵抗与冠状动脉钙化
J Am Coll Cardiol. 2008 Jul 15;52(3):231-6. doi: 10.1016/j.jacc.2008.04.016.
10
Coronary artery calcification, ADMA, and insulin resistance in CKD patients.慢性肾脏病患者的冠状动脉钙化、不对称二甲基精氨酸与胰岛素抵抗
Clin J Am Soc Nephrol. 2008 Sep;3(5):1289-95. doi: 10.2215/CJN.00010108. Epub 2008 Jun 18.

慢性肾脏病患者的冠状动脉钙化风险因素(来自慢性肾功能不全队列研究)。

Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).

机构信息

Tulane University School of Public Health and Tropical Medicine, and School of Medicine, New Orleans, Louisiana, USA.

出版信息

Am J Cardiol. 2012 Dec 15;110(12):1735-41. doi: 10.1016/j.amjcard.2012.07.044. Epub 2012 Sep 14.

DOI:10.1016/j.amjcard.2012.07.044
PMID:22980963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3511639/
Abstract

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). We examined the cross-sectional association between novel risk factors and coronary artery calcium (CAC) measured using electron beam computed tomography or multidetector computed tomography among 2,018 patients with CKD. Using the total Agatston scores, the participants were classified as having no (0), moderate (>0-100), or high (>100) CAC. After adjustment for age, gender, race, study sites, cigarette smoking, previous cardiovascular disease, hypertension, and diabetes, the use of lipid-lowering drugs, body mass index, waist circumference, and cystatin C, several novel risk factors were significantly associated with high CAC. For example, the odds ratios of high CAC associated with 1 SD greater level of risk factors were 1.20 (95% confidence interval 1.04 to 1.38) for serum calcium, 1.21 (95% confidence interval 1.04 to 1.41) for serum phosphate, 0.83 (95% confidence interval 0.71 to 0.97) for log (total parathyroid hormone), 1.21 (95% confidence interval 1.03 to 1.43) for log (homeostasis model assessment-insulin resistance), and 1.23 (95% confidence interval 1.04 to 1.45) for hemoglobin A1c. Additionally, the multivariate-adjusted odds ratio for 1 SD greater level of cystatin C was 1.31 (95% confidence interval 1.14 to 1.50). Serum high-sensitive C-reactive protein, interleukin-6, tumor necrosis factor-α, and homocysteine were not statistically significantly associated with high CAC. In conclusion, these data indicate that abnormal calcium and phosphate metabolism, insulin resistance, and declining kidney function are associated with the prevalence of high CAC, independent of the traditional risk factors in patients with CKD. Additional studies are warranted to examine the causal effect of these risk factors on CAC in patients with CKD.

摘要

心血管疾病是慢性肾脏病(CKD)患者死亡的主要原因。我们研究了 2018 例 CKD 患者中使用电子束计算机断层扫描或多排计算机断层扫描测量的新型危险因素与冠状动脉钙(CAC)的横断面相关性。根据总 Agatston 评分,参与者被分为无 CAC(0)、中度 CAC(>0-100)或高度 CAC(>100)。在调整年龄、性别、种族、研究地点、吸烟、既往心血管疾病、高血压和糖尿病、降脂药物使用、体重指数、腰围和胱抑素 C 后,几种新型危险因素与高 CAC 显著相关。例如,与危险因素 1 SD 增加相关的高 CAC 的比值比为血清钙 1.20(95%置信区间 1.04 至 1.38)、血清磷酸盐 1.21(95%置信区间 1.04 至 1.41)、全甲状旁腺激素对数 0.83(95%置信区间 0.71 至 0.97)、稳态模型评估-胰岛素抵抗对数 1.21(95%置信区间 1.03 至 1.43)和血红蛋白 A1c 1.23(95%置信区间 1.04 至 1.45)。此外,胱抑素 C 水平增加 1 SD 的多变量调整比值比为 1.31(95%置信区间 1.14 至 1.50)。血清高敏 C 反应蛋白、白细胞介素-6、肿瘤坏死因子-α和同型半胱氨酸与高 CAC 无统计学显著相关性。总之,这些数据表明,钙和磷酸盐代谢异常、胰岛素抵抗和肾功能下降与 CKD 患者 CAC 患病率相关,独立于 CKD 患者的传统危险因素。需要进一步研究来检查这些危险因素对 CKD 患者 CAC 的因果效应。